Role of nanomaterials with special reference to pharmaceutical technology

Abstract

Nanocarriers have emerged as a safe and effective method of medication administration and release during the past few years. When compared to their larger-scale counterparts, nanoparticles display amazing properties. The excellent biocompatibility of many of these carriers makes them more attractive, as does the fact that they provide better effectiveness, particularly in cancer therapies. Over the past half-century, nanocrystal, liposomal, and micelle nanocarriers for drug administration and release have been widely studied. As a result of these successful uses, the pharmaceutical industry now has a whole new product to choose from. An overview of recent works on nanocarrier materials and designs to improve the efficacy of medications for illness treatment is provided below. As organic and inorganic nanocarrier materials that are highly biocompatible and easy to manipulate get the most interest, specific emphasis is paid to the design and implementation of novel nanocarrier materials such as nanohydrogels, chitins, graphene oxides, and solid lipoprotein nanoparticles. Each summary shows how far the project has progressed. In order to give better therapy to patients, there is a pressing demand in pharmaceutical technology for improved knowledge of the current condition of these nanomaterials.